Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countries.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 10 2024
Historique:
received: 21 05 2024
accepted: 23 09 2024
medline: 29 10 2024
pubmed: 29 10 2024
entrez: 29 10 2024
Statut: epublish

Résumé

In this work our aim was to identify early biomarkers in plasma samples associated with mortality in children with perinatal HIV treated early in life, to potentially inform early intervention targeting this vulnerable group. 20/215 children (9.3%) with perinatal HIV, enrolled within 3 months of age died prematurely within the first year of the study, despite early ART initiation. Using a propensity score, we selected 40 alive study participants having similar clinical and virological records compared to the deceased group. 13 HIV unexposed (HU) healthy children were additionally used as controls. Baseline plasma samples were analyzed using a targeted proteomic approach, and to assess pathogen-associated and damage-associated molecular patterns (PAMPs, DAMPs) levels. Data from deceased participants were compared to both control groups, with multivariate logistic regression models used to evaluate the association between mortality and plasma proteins. We developed a machine learning model to predict mortality risk, finding that IL-6 and CXCL11 not only were higher in deceased children than Matched-children with HIV (p < 0.001 and p = 0.0034) but also predictive of mortality (accuracy of 77%); levels of PAMPs were higher in deceased children (p = 0.0016). Thus, measuring early inflammatory biomarkers, particularly IL-6, could help mortality risk prediction and potentially guide targeted interventions.

Identifiants

pubmed: 39468166
doi: 10.1038/s41598-024-74066-4
pii: 10.1038/s41598-024-74066-4
doi:

Substances chimiques

Biomarkers 0
Interleukin-6 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25792

Investigateurs

Paolo Rossi (P)
Silvia Faggion (S)
Daniel Gomez Pena (DG)
Inger Lindfors Rossi (IL)
Federica D'Ambrosio (F)
Andrea Oletto (A)
Francesca Mazzetto (F)
Musakanya Ching'andu (M)
Alessandra Nardone (A)
William James (W)
Nicola Cotugno (N)
Paola Zangari (P)
Carla Paganin (C)
Paolo Palma (P)
Alfredo Tagarro (A)
Anita De Rossi (A)
Sara Dominguez-Rodriguez (S)
Louise Kuhn (L)
Andrew Yates (A)
Mark F Cotton (MF)
Shaun Barnabas (S)
Avy Violari (A)
Kennedy Otwombe (K)
Paula Vaz (P)
Maria Grazia Lain (MG)
Moira Spyer (M)
Eleni Nastouli (E)
Kathleen Gartner (K)
Elisa López (E)
Sheila Fernandez-Luis (S)
Denise Naniche (D)
Tacilta Nhampossa (T)
Almoustapha Maiga (A)
Mariam Sylla (M)
Pablo Rojo (P)
Carlo Giaquinto (C)
Mathias Lichterfeld (M)
Nigel Klein (N)
Carlota Miranda (C)
Savita Pahwa (S)
Anne-Genevieve Marcelin (AG)
Vincent Calvez (V)
Caroline Foster (C)
Deborah Persaud (D)
Viviana Giannuzzi (V)
Annalisa Landi (A)
Adriana Ceci (A)
Ofer Levy (O)
Philip Goulder (P)
Holly Peay (H)
Thanyawee Puthanakit (T)
Cissy Kityo (C)

Informations de copyright

© 2024. The Author(s).

Références

Bassat, Q. et al. Causes of death among infants and children in the child health and mortality prevention surveillance (CHAMPS) network. JAMA Netw. Open 6, e2322494 (2023).
doi: 10.1001/jamanetworkopen.2023.22494 pubmed: 37494044 pmcid: 10372710
Perin, J. et al. Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc. Health 6, 106–115 (2022).
doi: 10.1016/S2352-4642(21)00311-4 pubmed: 34800370 pmcid: 8786667
Wang, Y., Zhao, Y., Bollas, A., Wang, Y. & Au, K. F. Nanopore sequencing technology, bioinformatics and applications. Nat. Biotechnol. 39, 1348–1365 (2021).
doi: 10.1038/s41587-021-01108-x pubmed: 34750572 pmcid: 8988251
Burstein, R. et al. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017. Nature 574, 353–358 (2019).
doi: 10.1038/s41586-019-1545-0 pubmed: 31619795 pmcid: 6800389
Agathis, N. T. et al. Mortality Among Children Aged <5 Years Living with HIV Who Are Receiving Antiretroviral Treatment - U.S. President’s Emergency Plan for AIDS Relief, 28 Supported Countries and Regions, October 2020-September 2022. MMWR Morb. Mortal. Wkly. Rep. 72, 1293–1299 (2023).
doi: 10.15585/mmwr.mm7248a1 pubmed: 38032949 pmcid: 10718201
Teasdale, C. A., Marais, B. J. & Abrams, E. J. HIV: prevention of mother-to-child transmission. BMJ Clin Evid 2011, 0909 (2011).
pubmed: 21477392 pmcid: 3217724
Domínguez-Rodríguez, S. et al. Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS. PLoS One 17, e0276116 (2022).
doi: 10.1371/journal.pone.0276116 pubmed: 36240212 pmcid: 9565414
Tanaka, T. & Kishimoto, T. The biology and medical implications of interleukin-6. Cancer Immunol. Res. 2, 288–294 (2014).
doi: 10.1158/2326-6066.CIR-14-0022 pubmed: 24764575
Wada, N. I. et al. Inflammatory biomarkers and mortality risk among HIV-suppressed men: A multisite prospective cohort study. Clin. Infect. Dis. 63, 984–990 (2016).
doi: 10.1093/cid/ciw409 pubmed: 27343547 pmcid: 5019283
Borges, Á. H. et al. Interleukin 6 is a stronger predictor of clinical events than high-sensitivity C-reactive protein or D-dimer during HIV infection. J. Infect. Dis. 214, 408–416 (2016).
doi: 10.1093/infdis/jiw173 pubmed: 27132283 pmcid: 4936649
Funderburg, N. T. et al. Interleukin 6 blockade with tocilizumab diminishes indices of inflammation that are linked to mortality in treated human immunodeficiency virus infection. Clin. Infect. Dis. 77, 272–279 (2023).
doi: 10.1093/cid/ciad199 pubmed: 37011013 pmcid: 10371305
Karin, N. CXCR3 ligands in cancer and autoimmunity, chemoattraction of effector T cells, and beyond. Front. Immunol. 11, 976 (2020).
doi: 10.3389/fimmu.2020.00976 pubmed: 32547545 pmcid: 7274023
Yin, X. et al. The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression. J. Transl. Med. 17, 417 (2019).
doi: 10.1186/s12967-019-02172-3 pubmed: 31836011 pmcid: 6909626
Pineda-Tenor, D. et al. CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients. J. Clin. Virol. 61, 423–429 (2014).
doi: 10.1016/j.jcv.2014.08.020 pubmed: 25218243
Aziz, N., Detels, R., Chang, L. C. & Butch, A. W. Macrophage inflammatory protein-3 alpha (MIP-3α)/CCL20 in HIV-1-infected individuals. J. AIDS Clin. Res. 7, 587 (2016).
doi: 10.4172/2155-6113.1000587 pubmed: 27617163 pmcid: 5015655
Dalzini, A. et al. Biological aging and immune senescence in children with perinatally acquired HIV. J. Immunol. Res. 2020, 8041616 (2020).
doi: 10.1155/2020/8041616 pubmed: 32509884 pmcid: 7246406
Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365–1371 (2006).
doi: 10.1038/nm1511 pubmed: 17115046
Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104–107 (2010).
doi: 10.1038/nature08780 pubmed: 20203610 pmcid: 2843437
Vénéreau, E., Ceriotti, C. & Bianchi, M. E. DAMPs from cell death to new life. Front. Immunol. https://doi.org/10.3389/fimmu.2015.00422 (2015).
doi: 10.3389/fimmu.2015.00422 pubmed: 26347745 pmcid: 4539554
Roh, J. S. & Sohn, D. H. Damage-associated molecular patterns in inflammatory diseases. Immune Netw. 18, e27 (2018).
doi: 10.4110/in.2018.18.e27 pubmed: 30181915 pmcid: 6117512
Hakim, J. et al. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. N Engl. J. Med. 377, 233–245 (2017).
doi: 10.1056/NEJMoa1615822 pubmed: 28723333 pmcid: 5603269
Tagarro, A. et al. High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries. eClinicalMedicine 73, 102648 (2024).
doi: 10.1016/j.eclinm.2024.102648 pubmed: 39411486 pmcid: 11473196
Venkatesh, K. K. et al. Morbidity and mortality among infants born to HIV-infected women in South Africa: implications for child health in resource-limited settings. J. Trop. Pediatr. 57, 109–119 (2011).
doi: 10.1093/tropej/fmq061 pubmed: 20601692
Oumer, A., Kubsa, M. E. & Mekonnen, B. A. Malnutrition as predictor of survival from anti-retroviral treatment among children living with HIV/AIDS in Southwest Ethiopia: survival analysis. BMC Pediatr. 19, 474 (2019).
doi: 10.1186/s12887-019-1823-x pubmed: 31801487 pmcid: 6892183
Ho, D. E., Imai, K., King, G. & Stuart, E. A. MatchIt: nonparametric preprocessing for parametric causal inference. J. Stat. Soft. https://doi.org/10.18637/jss.v042.i08 (2011).
doi: 10.18637/jss.v042.i08
Morrocchi, E. et al. Perinatally human immunodeficiency virus-infected adolescents and young adults demonstrate distinct BNT162b2 messenger RNA coronavirus disease 2019 vaccine immunogenicity. Clin. Infect. Dis. 75, S51–S60 (2022).
doi: 10.1093/cid/ciac408 pubmed: 35738253 pmcid: 9278233
Amodio, D. et al. Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children. Clin. Immunol. 255, 109751 (2023).
doi: 10.1016/j.clim.2023.109751 pubmed: 37660743
Petrara, M. R. et al. Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors. Cancer Lett. 469, 323–331 (2020).
doi: 10.1016/j.canlet.2019.10.045 pubmed: 31693921
Petrara, M. R. et al. Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus. PLoS ONE 12, e0185128 (2017).
doi: 10.1371/journal.pone.0185128 pubmed: 28926641 pmcid: 5605085
Kuhn, M. Building predictive models in R using the caret package. J. Stat. Soft. https://doi.org/10.18637/jss.v028.i05 (2008).
doi: 10.18637/jss.v028.i05
Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
doi: 10.1093/nar/28.1.27 pubmed: 10592173
Türei, D. et al. Integrated intra- and intercellular signaling knowledge for multicellular omics analysis. Mol. Syst. Biol. 17, e9923 (2021).
doi: 10.15252/msb.20209923 pubmed: 33749993 pmcid: 7983032

Auteurs

Elena Morrocchi (E)

Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA.

Giuseppe R Pascucci (GR)

Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA.

Nicola Cotugno (N)

Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Department of Systems Medicine, Molecular Medicine, and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.

Chiara Pighi (C)

Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Sara Dominguez-Rodriguez (S)

Instituto de Investigación Sanitaria Hospital 12 Octubre, Madrid, Spain.
Pediatrics Research Group, Universidad Europea de Madrid, Madrid, Spain.

Maria Raffaella Petrara (MR)

Section of Oncology and Immunology, DiSCOG, University of Padova, Padova, Italy.

Alfredo Tagarro (A)

Instituto de Investigación Sanitaria Hospital 12 Octubre, Madrid, Spain.
Pediatrics Department, Hospital Universitario Infanta Sofía, Infanta Sofia University Hospital and Henares University Hospital Foundation for Biomedical Research and Innovation (FIIB HUIS HHEN), San Sebastián de los Reyes, Madrid, Spain.
Pediatrics Research Group, Universidad Europea de Madrid, Madrid, Spain.

Louise Kuhn (L)

Gertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY, USA.

Mark F Cotton (MF)

Family Centre for Research With Ubuntu, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Kennedy Otwombe (K)

Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Maria G Lain (MG)

Fundação Ariel Glaser contra o SIDA Pediátrico, Maputo, Mozambique.

Paula Vaz (P)

Fundação Ariel Glaser contra o SIDA Pediátrico, Maputo, Mozambique.

Shaun L Barnabas (SL)

Family Centre for Research With Ubuntu, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Moira J Spyer (MJ)

University College London, Great Ormond Street Institute for Child Health, Infection, Immunity and Inflammation, London, UK.

Elisa Lopez (E)

ISGlobal, Barcelona Institute for Global Health, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Sheila Fernández-Luis (S)

ISGlobal, Barcelona Institute for Global Health, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Tacilta Nhampossa (T)

Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.

Almoustapha I Maiga (AI)

University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Oumar Dolo (O)

University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.

Anita De Rossi (A)

Section of Oncology and Immunology, DiSCOG, University of Padova, Padova, Italy.
Istituto Oncologico Veneto (IOV-IRCCS), Padua, Italy.

Pablo Rojo (P)

Universidad Computense de Madrid, Istituto de Investigación Hospital 12 de Octubre, Madrid, Spain.

Carlo Giaquinto (C)

Department for Women's and Children's Health, University of Padova, Via Giustiniani, 3 - 35128, Padua, Italy.
Penta - Child Health Research, Corso Stati Uniti, 4 - 35127, Padua, Italy.

Mathias Lichterfeld (M)

Infectious Disease Division, Brigham and Women's Hospital, Boston, MA, USA.
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.

Avy Violari (A)

Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Theresa Smit (T)

Africa Health Research Institute (AHRI), Durban, South Africa.

Osee Behuhuma (O)

Africa Health Research Institute (AHRI), Durban, South Africa.

Nigel Klein (N)

Africa Health Research Institute (AHRI), Durban, South Africa.
Great Ormond Street Institute for Child Health (GOS ICH), University College London (UCL), London, UK.

Lesley De Armas (L)

Department of Microbiology and Immunology, Miami Center for AIDS Research, Miller School of Medicine, University of Miami, Miami, USA.

Savita Pahwa (S)

Department of Microbiology and Immunology, Miami Center for AIDS Research, Miller School of Medicine, University of Miami, Miami, USA.

Paolo Rossi (P)

Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Department of Systems Medicine, Molecular Medicine, and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.

Paolo Palma (P)

Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. paolo.palma@opbg.net.
Department of Systems Medicine, Molecular Medicine, and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy. paolo.palma@opbg.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH